Peptide Initiative

Peptides · Peptide comparison

Capromorelin vs CJC-1295 (No DAC)

An oral ghrelin agonist originally developed by Pfizer that stimulates growth hormone and appetite. FDA-approved for veterinary use (Entyce and Elura) and investigated in human trials for age-related muscle wasting and appetite support.

A modified growth hormone-releasing hormone that boosts your body's natural GH pulses for better recovery, deeper sleep, and improved body composition [13] [17].

  • Growth Hormone
  • Growth Hormone

At a glance

Quick comparison

Dose rangeCapromorelin10–10 mgCJC-1295 (No DAC)100–100 mcg
FrequencyCapromorelinOnce dailyCJC-1295 (No DAC)Once daily
AdministrationCapromorelinOral (capsule or tablet)CJC-1295 (No DAC)Subcutaneous injection
Cycle lengthCapromorelin4-6 weeksCJC-1295 (No DAC)8-12 weeks
Onset speedCapromorelinModerate (1-2 weeks)CJC-1295 (No DAC)Moderate (1-2 weeks)
Evidence levelCapromorelinModerate human trials (Phase 1-2)CJC-1295 (No DAC)Moderate human trials (Phase 1-2)

Efficacy

Benefit ratings

GH & IGF-1 Stimulation

Capromorelin88%
CJC-1295 (No DAC)No recorded rating

Physical Function

Capromorelin82%
CJC-1295 (No DAC)No recorded rating

Oral Convenience

Capromorelin92%
CJC-1295 (No DAC)No recorded rating

GH Stimulation

CapromorelinNo recorded rating
CJC-1295 (No DAC)88%

Sleep Quality

CapromorelinNo recorded rating
CJC-1295 (No DAC)92%

Recovery Support

CapromorelinNo recorded rating
CJC-1295 (No DAC)85%

Technical data

Compound specifications

Capromorelin

Molecular formula
C28H35N5O4
Molecular weight
505.6 g/mol
Half-life
About 1.2 hours in dogs (ENTYCE label)
Bioavailability
44% oral in dogs and 65% in rats; no human figure published on this page
CAS number
193273-66-4

CJC-1295 (No DAC)

Molecular formula
C152H252N44O42
Molecular weight
3367.9 g/mol
Half-life
30 minutes to 2 hours
Bioavailability
~100% (subcutaneous)
CAS number
863288-34-0

Protocols

Dosing compared

Capromorelin

Oral

  • 3 mgTwice daily · Initial weeksOne of the lower doses tested in the year-long study in older adults; raised growth hormone and IGF-1 [1].
  • 10 mgOnce daily at bedtime · OngoingA simple once-daily bedtime dose used in the human trial that improved lean body mass [1].
  • 10 mgTwice daily · Up to 12 months in the trialThe highest daily amount studied in older adults (20 mg/day). The trial reported results for the pooled treatment groups, not the largest gains for this dose [1].

CJC-1295 (No DAC)

Subcutaneous

  • 100 mcgOnce daily, 30 minutes before bed · 2-4 weeksA common starting dose used in research practice. Because the no-DAC form is short-acting (about 30 minute half-life), it is injected on an empty stomach for the best growth-hormone pulse. [14][15]
  • 100 mcg per dose1-2 times daily · 8-12 weeksThe typical maintenance dose used in practice, often given before bed and/or after fasted exercise. Frequently paired with a GH-releasing peptide.
  • 100 mcg per dose2-3 times daily · 8-12 weeksA higher-frequency plan used by experienced users to mimic natural GH pulses across the day, each dose taken fasted.

Applications

Best suited for

Capromorelin

Age-Related Muscle Wasting
Capromorelin showed significant improvements in physical function — including tandem walk and stair climb — in elderly adults, making it a strong candidate for combating sarcopenia.
Appetite Stimulation
As an FDA-approved veterinary appetite stimulant, capromorelin has extensive real-world evidence for boosting food intake and body weight in mammals.
Growth Hormone Research
One of the best-studied oral ghrelin agonists with human Phase 2 data, offering researchers a well-characterized tool for studying GH/IGF-1 pathways.

CJC-1295 (No DAC)

Natural Growth Hormone Optimization
Perfect for those wanting to boost their body's own GH production rather than using synthetic growth hormone. Mimics the natural pulsatile release pattern your pituitary uses [2].
Workout Recovery and Muscle Building
Athletes and fitness enthusiasts use it to accelerate recovery between training sessions, support lean muscle development, and reduce body fat over time [17] [18].
Sleep Quality Enhancement
Because GH is naturally released during deep sleep, many users report dramatically improved sleep quality with more vivid dreams and feeling more refreshed upon waking [12] [13].
Anti-Aging and Vitality
As GH levels decline with age, CJC-1295 helps restore more youthful hormone patterns, potentially improving skin quality, energy levels, and overall well-being [16] [17] [20].
Synergistic Peptide Stacking
Designed to work hand-in-hand with GHRPs like Ipamorelin. When combined, these peptides amplify each other's effects for significantly greater GH release than either alone [9].

Safety profile

Side effects

Capromorelin

Common

  • Appetite stimulation
  • Fluid retention and weight gain

Uncommon

  • Joint and muscle aches
  • Fatigue or lethargy
  • Peripheral edema (swelling)

Serious

  • Hyperglycemia

CJC-1295 (No DAC)

Common

  • Injection site reactions
  • Flushing or warmth
  • Water retention
  • Increased appetite

Uncommon

  • Tingling or numbness
  • Headache

Serious

  • Allergic reaction

Research status

Safety & evidence

Capromorelin

Evidence level
Moderate human trials (Phase 1-2)
FDA status
Not approved for human use. FDA-approved for veterinary use only: ENTYCE (appetite stimulation in dogs, 2016) and ELURA (weight loss in cats with chronic kidney disease, 2020); both labels state "not for use in humans".
Safety overview
Capromorelin was generally well-tolerated in Phase 2 human trials involving nearly 400 elderly participants. Most side effects were mild to moderate. Its FDA-approved veterinary use provides additional long-term safety data in mammalian species.

Contraindications

  • Active cancer or history of cancer (GH may stimulate growth)
  • Uncontrolled diabetes or severe metabolic disorders
  • Severe liver or kidney disease
  • Pregnancy and lactation

CJC-1295 (No DAC)

Evidence level
Moderate human trials (Phase 1-2)
FDA status
Research compound
Safety overview
CJC-1295 without DAC itself has not been evaluated in controlled human clinical trials; expectations about its safety are extrapolated from studies of related GHRH analogs. The most common side effects are mild and include injection site reactions and temporary flushing [19]. Because it stimulates natural GH release rather than providing exogenous GH, it maintains the body's feedback mechanisms [2].

Contraindications

  • Active cancer or history of cancer
  • Pregnancy or breastfeeding
  • Pituitary tumors or disorders
  • Hypersensitivity to GHRH analogs
  • Diabetic retinopathy

Decision guide

Which is right for you?

Capromorelin

Choose Capromorelin if…

  • Stimulating growth hormone production in elderly adults
  • Supporting appetite and weight gain in wasting conditions
  • Improving muscle mass and physical performance
  • Anti-aging and longevity optimization

CJC-1295 (No DAC)

Choose CJC-1295 (No DAC) if…

  • Increasing natural growth hormone levels
  • Building lean muscle mass
  • Improving sleep quality
  • Enhancing workout recovery